NCT00587678View on ClinicalTrials.gov

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Peripheral Artery Disease
Interventions
DRUG

Simvastatin

40mg each night

DRUG

Ezetimibe

10mg daily

DRUG

Simvastatin/Ezetimibe

40mg/10mg each night

Trial Locations (1)

22908

University of Virgina Health System, Charlottesville

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Virginia

OTHER

NCT00587678 - Comprehensive Magnetic Resonance of Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter